Similar articles

• Altruism among participants in cancer clinical trials.

  Truong TH, Weeks JC, Cook EF, Joffe S. Truong TH, et al. Clin Trials. 2011 Oct;8(5):616-23. doi: 10.1177/1740774511414444. Epub 2011 Aug 3. Clin Trials. 2011. PMID: 21813584
• [Clinical trials--viewpoints from participants].

  Langslet G, Ottestad I, Retterstøl K, Ose L. Langslet G, et al. Tidsskr Nor Laegeforen. 2010 Aug 26;130(16):1606-8. doi: 10.4045/tidsskr.09.0030. Tidsskr Nor Laegeforen. 2010. PMID: 20805857 Norwegian.
• Patients' motives for consenting or refusing to participate in a clinical trial in organ transplantation.

  Guedj M, Ballester S, Kamar N, Rostaing L, Donckier V, Goldman M, Cambon-Thomsen A. Guedj M, et al. Clin Transplant. 2013 Sep-Oct;27(5):724-31. doi: 10.1111/ctr.12214. Epub 2013 Sep 6. Clin Transplant. 2013. PMID: 24033357
• Factors determining participation in prevention trials among systemic lupus erythematosus patients: a qualitative study.

  Costenbader KH, Brome D, Blanch D, Gall V, Karlson E, Liang MH. Costenbader KH, et al. Arthritis Rheum. 2007 Feb 15;57(1):49-55. doi: 10.1002/art.22480. Arthritis Rheum. 2007. PMID: 17266094
• Why patients don't take part in cancer clinical trials: an overview of the literature.

  Cox K, McGarry J. Cox K, et al. Eur J Cancer Care (Engl). 2003 Jun;12(2):114-22. doi: 10.1046/j.1365-2354.2003.00396.x. Eur J Cancer Care (Engl). 2003. PMID: 12787008 Review.